| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:445700282:2116 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:445700282:2116?format=raw |
LEADER: 02116cam a22004698i 4500
001 3903247
005 20221026234952.0
008 801009t19801980nyu b 101 0 eng
010 $a 79022555
020 $a0306403102 (v. 1)
020 $a0306403110 (v. 2)
035 $a(OCoLC)5513629
035 $a(OCoLC)ocm05513629
035 $a(CStRLIN)NYCG18992625-B
035 $9AAD3618HS
035 $a(NNC)3903247
035 $a3903247
040 $dNNC-M$dCStRLIN
050 00 $aQP801.P8$bI56 1979
082 0 $a612/.0157
111 2 $aInternational Symposium on Purine Metabolism in Man$n(3rd :$d1979 :$cMadrid, Spain)
245 10 $aPurine metabolism in man, III /$cedited by A. Rapado, R. W. E. Watts, and C. H. M. M. De Bruyn.
260 $aNew York :$bPlenum Press,$c[1980], ©1980.
300 $a2 volumes :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAdvances in experimental medicine and biology ;$vv. 122A-122B
504 $aIncludes bibliographical references and index.
505 0 $a[1] Clinical and therapeutic aspects.--[2] Biochemical, immunological, and cancer research.
650 0 $aPurines$xMetabolism$vCongresses.
650 0 $aHyperuricemia$vCongresses.
650 0 $aImmunopathology$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008123077
650 0 $aCancer$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008100049
650 2 $aPurine-Pyrimidine Metabolism, Inborn Errors.$0https://id.nlm.nih.gov/mesh/D011686
650 2 $aPurines$xmetabolism.$0https://id.nlm.nih.gov/mesh/D011687Q000378
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aRapado, Aurelio.$0http://id.loc.gov/authorities/names/n85360779
700 1 $aWatts, R. W. E.$0http://id.loc.gov/authorities/names/n79113272
700 1 $aBruyn, Chris H. M. M. de.$0http://id.loc.gov/authorities/names/n79114655
830 0 $aAdvances in experimental medicine and biology ;$vv. 122A-B.$0http://id.loc.gov/authorities/names/n42001229
852 01 $boff,hsl$hQP801.P8$iIn8 1979
866 30 $80$apt. A-B